Skip to main content
SpringerLink
Log in

Model Features of a Cardiac lontophoretic Drug Delivery Implant

  • Note
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. K. T. Heruth. Medtronic synchromed drug administration system. Ann. N. Y. Acad. Sci. 531:72–75 (1988).

    Google Scholar 

  2. J. Kost, K. Leong, and R. Langer. Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc. Natl. Acad. Sci. U.S.A. 86:7663–7666 (1989).

    Google Scholar 

  3. E. R. Edelman, L. Brown, J. Taylor, and R. Langer. In vitro and in vivo kinetics of regulated drug release from polymer matrices by oscillating magnetic fields. J. Biomed. Mater Res. 21:339–353 (1987).

    Google Scholar 

  4. J. Kost and R. Langer. Responsive polymeric delivery systems. Adv. Drug. Del. Rev. 6:19–50 (1991).

    Google Scholar 

  5. J. B. Phipps and J. A. Gyory. Transdermal ion migration. Adv. Drug Del. Rev. 9:137–176 (1992).

    Google Scholar 

  6. G. B. Kasting. Theoretical models for iontophoretic delivery. Adv. Drug Del. Rev. 9:177–199 (1992).

    Google Scholar 

  7. S. P. Schwendeman, G. L. Amidon, M. E. Meyerhoff, and R. J. Levy, Modulated drug release using iontophoresis through heterogeneous cation-exchange membranes: membrane preparation and influence of resin cross-linkage. Macromolecules 25:2531–2540 (1992).

    Google Scholar 

  8. S.P. Schwendeman, G. L. Amidon, V. Labhasetwar, and R. J. Levy, Modulated drug release using iontophoresis through heterogeneous cation-exchange membranes II: influence of cation-exchanger content on membrane resistance and characteristic times. J. Pharm Sci., 83:1482–1494 (1994).

    Google Scholar 

  9. S. P. Schwendeman, G. L. Amidon, and R. J. Levy, Determinants of the modulated release of antiarrhythmic drugs by iontophoresis through polymer membranes. Macromolecules 26:2264–2272 (1993).

    Google Scholar 

  10. J. W. Boretos. Silicones. Polym. Sci. Technol. 8:87–98 (1975).

    Google Scholar 

  11. A. Waldo and A Wit. Mechanisms of cardiac arrhythmias. The Lancet 341:1189–1193 (1993).

    Google Scholar 

  12. A. Sintov, W. A. Scott, R. Siden, and R. J. Levy. Efficacy of epicardial controlled-release lidocaine for ventricular tachycardia induced by rapid ventricular pacing in dogs. J. Cardiovasc. Pharmacol. 16:812–817 (1990).

    Google Scholar 

  13. V. Labhasetwar, A. Kadish, T. Underwood, M. Sirinek, and R. J. Levy. The efficacy of controlled release d-sotalol-polyurethane epicardial implants for ventricular arrhythmias due to acute ischemia in dogs. J. Controlled Release 23:75–86 (1993).

    Google Scholar 

  14. A. Sintov, W. A. Scott, K. P. Gallagher, and R. J. Levy. Conversion of ouabain-induced ventricular tachycardia in dogs with epicardial lidocaine: pharmacodynamics and functional effects. Pharm. Res. 7:28–33 (1990).

    Google Scholar 

  15. A. Sintov., W. Scott, M. Dick, and R. J. Levy. Cardiac controlled release for arrhythmia therapy: lidocaine-polyurethane matrix studies. J. Controlled Release 8:157–168 (1988).

    Google Scholar 

  16. R. Siden, A. Kadish, W. Flowers, L. Kutas, B. K. Bieneman, J. DePietro, J. P. Jenkins, K. P. Gallagher, and R. J. Levy. Epicardial controlled-release verapamil prevents ventricular tachycardia episodes induced by acute ischemia in a canine model. J. Cardiocasc. Pharmacol. 19:798–809 (1992).

    Google Scholar 

  17. V. Labhasetwar, T. Underwood, M. Gallagher, G., Murphy, J. Langberg, and R. J. Levy, Sotalol controlled-release systems for arrhythmias: in vitro characterization, in vivo drug disposition, and electrophysiologic effects. J. Pharm. Sci., 83:157–169 (1994).

    Google Scholar 

  18. V. Labhasetwar, T. Underwood, M. Gallagher, J. Langberg, and R. J. Levy. Epicardial controlled-release ibutilide: effects on defibrillation threshold and electrophyiologic parameters. J. Cardiovasc. Pharmacol. 24:826–840 (1994).

    Google Scholar 

  19. W. Chen, S. P. Schwendeman, V. Labhasetwar, and R. J. Levy. Techniques in cardiovascular drug delivery-surfactant derivatization, polymer implants, and iontophoresis, in Polymeric Site-specific Pharmacotherapy, A. J. Domb (ed.), John Wiley & Sons, N.Y., 1994, pp. 221–242.

    Google Scholar 

  20. V. Labhasetwar, T. Underwood, S. P. Schwendeman, and R. J. Levy. Iontophoresis for modulation of cardiac drug delivery. Proc. Natl. Acad. Sci USA, in press.

  21. S. P. Schwendeman, R. J. Levy, H. A. Murphy, and G. L. Amidon. Influence of the silicone rubber matrix on the iontophoretc transport through heterogeneous cation-exchange membranes. Pharm. Res. 8:S-141 (1991).

    Google Scholar 

  22. J. O'M. Bockris and A. K. N. Reddy. Modern Electrochemistry Vol I., Plenum Press, N.Y., 1970.

    Google Scholar 

  23. W. E. Morf. The Principles of Ion-selective Electrodes and of Membrane Transport, Elsevier Scientific Publishing Company, N.Y., 1981.

    Google Scholar 

  24. K. J. Vetter. Electrochemical Kinetics, Academic Press, N.Y., 1967.

    Google Scholar 

  25. H. G. Mond. Permanent cardiac pacemakers: techniques of implantation, testing and surveillance, in Hurst's The Heart, R. C. Schlant, R. W. Alexander, W. O'Rourke, R. Roberts, and E. H. Sonnenblick (eds.), McGraw Hill, Inc., N. Y., 1994, p. 823.

    Google Scholar 

  26. The Merck Index, 11th ed., Merck&Co., Inc., Rahway, NJ, 1982.

  27. R. C. Reid, J. M. Prausnitz, and T. K. Sherwood. The Properties of Gases and Liquids, 3rd ed., McGraw Hill Book Company, N. Y., 1977.

    Google Scholar 

  28. Perry's Chemical Engineers' Handbook, 6th ed., R. H. Perry and D. Green (eds.), McGraw-Hill Book Company, N. Y., 1984, pp. 3–76, 3–83.

    Google Scholar 

  29. J. N. Agar. Diffusion and convection at electrodes. Disc Faraday. Soc., 1:26–37 (1947).

    Google Scholar 

Download references

Author information

Author notes

  1. Steven P. Schwendeman

    Present address: Department of Chemical Engineering, Massachusetts Institute of Technology, E25-342, Cambridge, Massachusetts, 02139

Authors and Affiliations

  1. Department of Pediatrics and Communicable Diseases, and the College of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109-0576

    Steven P. Schwendeman, Vinod Labhasetwar & Robert J. Levy

Authors
  1. Steven P. Schwendeman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vinod Labhasetwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert J. Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwendeman, S.P., Labhasetwar, V. & Levy, R.J. Model Features of a Cardiac lontophoretic Drug Delivery Implant. Pharm Res 12, 790–795 (1995). https://doi.org/10.1023/A:1016288315617

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016288315617

Search

Navigation